Skip to content

Metro Atlanta Heart Disease Study - II (MAHDS II)

Multiple CVD Risk Reduction in Adult African-Americans: A Pilot Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01235702
Enrollment
210
Registered
2010-11-05
Start date
2002-09-30
Completion date
2003-10-31
Last updated
2010-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

African Americans With Hypertension.

Keywords

high blood pressure, hypertension, African Americans, perceived stress

Brief summary

A 12-week treatment/control trial was implemented to assess the effects of a multi component lifestyle program on improvements in body mass index, weight, perceived stress and blood pressure in African American men and women who were at increased risk for cardiovascular disease. It was hypothesized that treatment group would experience significant improvements when compared to the control group.

Interventions

BEHAVIORAL12-week lifestyle modification

Sponsors

Morehouse School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

African American men and women aged \>21 with elevated blood pressure and excess body weight who resided in metro Atlanta, GA. \-

Exclusion criteria

Individuals with normal blood pressure and body weight, as well as those residing outside of metro Atlanta, GA. Individuals with psychological conditions were also excluded. \-

Design outcomes

Primary

MeasureTime frameDescription
blood pressure10/2002 - 11/2003a 12-week behavior modification program was implemented to assess the effects of nutrition counseling, stress reduction education, and directed physical activity on African Americans at increased risk for cardiovascular disease.

Secondary

MeasureTime frame
body weight10/2002 - 11/2003

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026